​

Abeona Therapeutics Ownership | Who Owns Abeona Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Abeona Therapeutics Ownership Summary

Abeona Therapeutics is owned by 5.18% insiders, and 94.81% retail investors. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.68% of its assets in Abeona Therapeutics shares.

ABEO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAbeona Therapeutics-5.18%94.81%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-2,350---1---
Sep 30, 20222-94.44%153,702-99.26%21.16%--100.00%2-60.00%
Jun 30, 202236-26.53%20,889,690-35.97%142.84%11-31.25%5-66.67%
Mar 31, 2022494.26%32,623,572-20.40%221.30%16-27.27%1525.00%
Dec 31, 202147-16.07%40,985,64961.98%416.24%2222.22%12-36.84%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor1.53M2.68%-
Vanguard Total Stock Mkt Idx Inv1.53M2.68%-
Vanguard US Total Market Shares ETF1.23M2.53%-
iShares Russell 2000 ETF1.16M2.03%-20.64K
Kennedy Micro Cap767.11K1.35%-107.47K
abrdn Life Sciences Investors616.41K1.12%-
Vanguard Institutional Extnd Mkt Idx Tr627.77K1.10%48.64K
Fidelity Small Cap Index464.81K0.82%8.19K
iShares Russell 2000 Value ETF403.01K0.71%-
Kennedy Micro Cap Opportunities381.16K0.67%-5.87K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 21, 2026Vazzano Joseph Walter Chief Financial OfficerSell$9.65K
Jul 09, 2026Vazzano Joseph Walter Chief Financial OfficerSell$173.26K
Jul 09, 2026Seshadri Vishwas Chief Executive OfficerSell$473.33K
Jul 09, 2026O'Malley Brendan M. SVP, Chief Legal OfficerSell$83.91K
Jul 09, 2026Vasanthavada Madhav Chief Commercial OfficerSell$87.78K

Insider Transactions Trends

DateBuySell
2026 Q3-5
2026 Q2-14
2026 Q1-12
2025 Q4-3
2025 Q3-15

ABEO Ownership FAQ

Who Owns Abeona Therapeutics?

Abeona Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 5.18% insiders and 94.82% retail investors. The average institutional ownership in Abeona Therapeutics's industry, Biotech Stocks , is 35.43%, which Abeona Therapeutics falls below.

Does Blackrock own Abeona Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Abeona Therapeutics.

Who is the top mutual fund holder of Abeona Therapeutics shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Abeona Therapeutics shares, with 2.68% of its total shares outstanding invested in 1.53M Abeona Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools